Cognitive affective psychosis syndrome in a patient with sporadic olivopontocerebellar atrophy.
Duggal
Harpreet S
HS
D000293:Adolescent; D000341:Affective Disorders, Psychotic / Q000209:etiology* / Q000523:psychology*; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002531:Cerebellum / Q000000981:diagnostic imaging; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006212:Hallucinations / Q000209:etiology / Q000523:psychology; D006801:Humans; D009849:Olivopontocerebellar Atrophies / Q000150:complications* / Q000523:psychology*; D010259:Paranoid Disorders / Q000209:etiology / Q000523:psychology; D018967:Risperidone / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D014282:Trihexyphenidyl / Q000627:therapeutic use
D018726:Anti-Dyskinesia Agents; D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D005473:Fluoxetine; D014282:Trihexyphenidyl; D018967:Risperidone